Income Statement Tibet Duo Rui Pharmaceutical Co., Ltd.

Stocks

301075

CNE100004RW5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 26/06/2026			5-day change	1st Jan Change
59.21 ^CNY	-6.87%		-11.77%	-0.77%

28/04	Tibet Duo Rui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
23/04	Tibet Duo Rui Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

c867624a8e705f1351e.ktVjZhs4q7Xsk1T7yExWaKwp-ulWe7b-8gj1vMTJaNk.xvgkHmph7uGa22fPnB0kDtgfrcQwOvHMqmyi3oePDLbDgQAAYnff7IfcHQ

Published financial data: TIBET DUO RUI PHARMACEUTICAL CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	53Cr	40Cr	33Cr	24Cr	15Cr
Other Revenues, Total	-	68.64T	6L	7L	-
Total Revenues	53Cr	40Cr	33Cr	24Cr	15Cr
Cost of Goods Sold, Total	6.04Cr	9.27Cr	11Cr	15Cr	14Cr
Gross Profit	47Cr	31Cr	23Cr	9.18Cr	1.26Cr
Selling General & Admin Expenses, Total	37Cr	27Cr	20Cr	14Cr	8Cr
Provision for Bad Debts	13.57L	26.97L	-10L	56.38L	-
R&D Expenses	2.41Cr	2.65Cr	2.4Cr	3.7Cr	3.24Cr
Other Operating Expenses	65.92L	46.43L	36.96L	19.32L	-52.9L
Other Operating Expenses, Total	41Cr	31Cr	23Cr	18Cr	11Cr
Operating Income	6.24Cr	18.12L	-7L	-8.78Cr	-9.45Cr
Interest Expense, Total	-11.79L	-13.6L	-31.13L	-79L	-
Interest And Investment Income	11.64L	93L	1.34Cr	1.01Cr	9L
Net Interest Expenses	-14.79T	79.4L	1.02Cr	21.72L	9L
Other Non Operating Income (Expenses)	-72.92T	-2L	-55.6T	-17.44L	-3.16Cr
EBT, Excl. Unusual Items	6.23Cr	95.48L	94.45L	-8.74Cr	-13Cr
Impairment of Goodwill	-	-	-3.27T	-2L	-
Gain (Loss) On Sale Of Investments	-2L	-	66T	5L	38.58T
Gain (Loss) On Sale Of Assets	-	-	82.89T	43.53T	-1L
Asset Writedown	-625	-6.05T	-8.3T	-45.28T	-59.92L
Insurance Settlements	-	-	-	-	-
Other Unusual Items	1.12Cr	1.15Cr	1.27Cr	13.09L	-
EBT, Incl. Unusual Items	7.33Cr	2.1Cr	2.22Cr	-8.58Cr	-13Cr
Income Tax Expense	74.18L	24.41L	51.57L	-7L	10.44L
Earnings From Continuing Operations	6.59Cr	1.86Cr	1.71Cr	-8.5Cr	-13Cr
Net Income to Company	6.59Cr	1.86Cr	1.71Cr	-8.5Cr	-13Cr
Minority Interest	26.47L	19.18L	17.59L	2.24Cr	3.02Cr
Net Income - (IS)	6.85Cr	2.05Cr	1.89Cr	-6.27Cr	-10Cr
Net Income to Common Incl Extra Items	6.85Cr	2.05Cr	1.89Cr	-6.27Cr	-10Cr
Net Income to Common Excl. Extra Items	6.85Cr	2.05Cr	1.89Cr	-6.27Cr	-10Cr
Per Share Items
Net EPS - Basic	1.05	0.26	0.24	-0.79	-1.29
Basic EPS - Continuing Operations	1.05	0.26	0.24	-0.79	-1.29
Basic Weighted Average Shares Outstanding	6.52Cr	7.89Cr	7.85Cr	7.93Cr	7.92Cr
Net EPS - Diluted	1.05	0.26	0.24	-0.79	-1.29
Diluted EPS - Continuing Operations	1.05	0.26	0.24	-0.79	-1.29
Diluted Weighted Average Shares Outstanding	6.52Cr	7.89Cr	7.85Cr	7.93Cr	7.92Cr
Normalized Basic EPS	0.64	0.1	0.1	-0.41	-0.61
Normalized Diluted EPS	0.64	0.1	0.1	-0.41	-0.61
Dividend Per Share	0.62	-	0.12	-	-
Payout Ratio	1.68	247.95	17.26	-27.25	-8.6
Supplemental Items
EBITDA	7.61Cr	1.64Cr	1.74Cr	-6.11Cr	-4.54Cr
EBITA	6.28Cr	23.29L	-90.88T	-8.68Cr	-9.23Cr
EBIT	6.24Cr	18.12L	-7L	-8.78Cr	-9.45Cr
EBITDAR	7.9Cr	1.97Cr	2.05Cr	-5.91Cr	-
Total Revenues (As Reported)	53Cr	40Cr	33Cr	24Cr	-
Effective Tax Rate - (Ratio)	10.12	11.61	23.18	0.87	-0.79
Current Domestic Taxes	75.35L	25.66L	57.37L	15.82L	-
Total Current Taxes	75.35L	25.66L	57.37L	15.82L	-
Deferred Domestic Taxes	-1L	-1L	-6L	-23.28L	-
Total Deferred Taxes	-1L	-1L	-6L	-23.28L	-
Normalized Net Income	4.16Cr	78.86L	76.62L	-3.23Cr	-4.81Cr
Interest on Long-Term Debt	75.75T	61.28T	35.64T	2L	-
Supplemental Operating Expense Items
Advertising Expense	32Cr	22Cr	15Cr	6.26Cr	-
Selling and Marketing Expenses	33Cr	23Cr	16Cr	8.07Cr	2.31Cr
General and Administrative Expenses	4.72Cr	4.02Cr	3.89Cr	5.35Cr	5.69Cr
Research And Development Expense From Footnotes	2.41Cr	2.65Cr	2.4Cr	3.7Cr	3.24Cr
Net Rental Expense, Total	29.04L	32.85L	31.39L	19.73L	-
Imputed Operating Lease Interest Expense	10L	6L	6L	3L	-
Imputed Operating Lease Depreciation	19.18L	26.97L	25.83L	16.26L	-
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	61Cr	43Cr	41Cr	26Cr	8.53Cr
Trading Asset Securities, Total	-	8Cr	7.76Cr	14Cr	2Cr
Total Cash And Short Term Investments	61Cr	51Cr	48Cr	40Cr	11Cr
Accounts Receivable, Total	10Cr	9.23Cr	8.55Cr	11Cr	8.79Cr
Other Receivables	22.78L	78.79L	1.12Cr	1.95Cr	1.71Cr
Total Receivables	10Cr	10Cr	9.67Cr	13Cr	10Cr
Inventory	98.24L	3.28Cr	3.31Cr	4.58Cr	8.35Cr
Prepaid Expenses	56.35T	56.35T	47.52T	1.26T	-
Other Current Assets, Total	56.38L	86.58L	3.62Cr	5.36Cr	3.52Cr
Total Current Assets	73Cr	65Cr	65Cr	63Cr	33Cr
Gross Property Plant And Equipment	17Cr	19Cr	30Cr	78Cr	-
Accumulated Depreciation	-6.3Cr	-7.6Cr	-9.48Cr	-13Cr	-
Net Property Plant And Equipment	10Cr	11Cr	21Cr	65Cr	69Cr
Long-term Investments	-	11Cr	16Cr	11Cr	11Cr
Goodwill	-	-	36.85L	1.92Cr	1.87Cr
Other Intangibles, Total	1.69Cr	2.12Cr	3.42Cr	7.85Cr	7.66Cr
Deferred Tax Assets Long-Term	7L	8L	12.54L	30.86L	34.86L
Deferred Charges Long-Term	14.55L	3L	27L	28.36L	20.07L
Other Long-Term Assets, Total	-	57.99L	1.63Cr	3.96Cr	4.78Cr
Total Assets	85Cr	90Cr	107.23Cr	153.5Cr	128.32Cr
Liabilities
Accounts Payable, Total	2.3Cr	1.21Cr	2.68Cr	5.81Cr	7.73Cr
Accrued Expenses, Total	1.05Cr	1.31Cr	85.85L	90.02L	72.47L
Short-term Borrowings	2Cr	10Cr	5.01Cr	28Cr	6.78Cr
Current Portion of Long-Term Debt	-	-	1.1Cr	12Cr	11Cr
Current Portion of Leases	5L	3L	6L	30.25L	-
Current Income Taxes Payable	28.69L	13.52L	24.12L	12.6L	4L
Unearned Revenue Current, Total	37.18L	41.6L	50.83L	27.78L	75.49L
Other Current Liabilities	22.51L	1.35Cr	2.46Cr	4.44Cr	17Cr
Total Current Liabilities	6.28Cr	14Cr	13Cr	51Cr	44Cr
Long-Term Debt	-	-	12Cr	14Cr	8.85Cr
Long-Term Leases	-	9L	3L	72.13L	37.31L
Unearned Revenue Non Current	-	-	21.21L	11Cr	11Cr
Deferred Tax Liability Non Current	-	-	9L	2.05Cr	2.03Cr
Total Liabilities	6.28Cr	15Cr	25Cr	78Cr	66Cr
Common Stock, Total	8Cr	8Cr	8Cr	8Cr	8Cr
Additional Paid In Capital	52Cr	51Cr	51Cr	51Cr	51Cr
Retained Earnings	19Cr	16Cr	18Cr	11Cr	74.74L
Treasury Stock	-	-	-	-2.1Cr	-2.1Cr
Comprehensive Income and Other	-	-12.96L	7L	11.37L	11.37L
Total Common Equity	79Cr	75Cr	77Cr	68Cr	57Cr
Minority Interest	-42.85L	18.89L	4.96Cr	7.67Cr	4.9Cr
Total Equity	79Cr	75Cr	82Cr	75Cr	62Cr
Total Liabilities And Equity	85Cr	90Cr	107.23Cr	153.5Cr	128.32Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	8Cr	8Cr	8Cr	7.9Cr	7.91Cr
ECS Total Common Shares Outstanding	8Cr	8Cr	8Cr	7.9Cr	7.91Cr
Book Value / Share	9.91	9.39	9.65	8.57	7.26
Tangible Book Value	78Cr	73Cr	73Cr	58Cr	48Cr
Tangible Book Value Per Share	9.7	9.13	9.18	7.33	6.05
Total Debt	2.05Cr	10Cr	18Cr	54Cr	27Cr
Net Debt	-59Cr	-40Cr	-30Cr	13Cr	17Cr
Debt Equivalent Oper. Leases	2.32Cr	2.63Cr	2.51Cr	1.58Cr	-
Minority Interest, Total (Incl. Fin. Div)	-42.85L	18.89L	4.96Cr	7.67Cr	4.9Cr
Equity Method Investments, Total	-	8.29Cr	8.58Cr	2.98Cr	-
Account Code - Inventory Valuation	5	5	5	5	-
Inventories - Raw Materials, Total	49.99L	65.12L	1.06Cr	1.22Cr	-
Inventories - Work In Process, Total	-	-	25.07L	76.15L	-
Inventories - Finished Goods, Total	49.19L	2.66Cr	2.11Cr	3.8Cr	-
Buildings, Total	16Cr	12Cr	17Cr	51Cr	-
Machinery, Total	-	6.35Cr	13Cr	25Cr	-
Full Time Employees	299	318	395	484	-
Accumulated Allowance for Doubtful Accounts (Supple)	60.57L	68.78L	72.64L	1.29Cr	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	6.85Cr	2.05Cr	1.89Cr	-6.27Cr	-13Cr
Depreciation & Amortization - CF	1.43Cr	1.52Cr	1.8Cr	2.82Cr	5.01Cr
Amortization of Goodwill and Intangible Assets - (CF)	5L	5L	7L	10.4L	21.95L
Depreciation & Amortization, Total	1.48Cr	1.57Cr	1.87Cr	2.93Cr	5.23Cr
Amortization of Deferred Charges, Total - (CF)	11.29L	12.05L	6L	5L	3L
(Gain) Loss From Sale Of Asset	-	-	-82.89T	-43.53T	1L
(Gain) Loss on Sale of Investments - (CF)	-2L	-3L	-56.48L	-53.31L	-9L
Asset Writedown & Restructuring Costs	14.51L	30.66L	39.5T	-3L	67.81L
Provision and Write-off of Bad Debts	-	-	-	56.38L	-
Other Operating Activities, Total	-14.69L	-39.83L	-23.42L	-57.62L	2.98Cr
Change In Accounts Receivable	65.69L	-48.71L	-1.3Cr	-3.24Cr	1.63Cr
Change In Inventories	49.1L	-2.33Cr	29.06L	-1.89Cr	-4.35Cr
Change In Accounts Payable	-4.75Cr	-67.52L	-71.54L	2.52Cr	2.6Cr
Change In Deferred Taxes	-1L	-1L	-5L	-23.28L	-6L
Change in Other Net Operating Assets	-	-	-	-	-
Cash from Operations	4.81Cr	11.27L	1.24Cr	-6.72Cr	-4.58Cr
Capital Expenditure	-53.46L	-3.27Cr	-2.37Cr	-4.09Cr	-10Cr
Sale of Property, Plant, and Equipment	-	8T	6L	-	8L
Cash Acquisitions	-	-	-3.51Cr	-4.8Cr	-
Divestitures	-	-	5L	6Cr	88L
Investment in Marketable and Equity Securities, Total	0	-18Cr	-4.53Cr	-17Cr	11Cr
Other Investing Activities, Total	-11Cr	1.49Cr	3.46Cr	35.78L	16Cr
Cash from Investing	-12Cr	-20Cr	-6.84Cr	-19Cr	17Cr
Short Term Debt Issued, Total	5Cr	10Cr	-	19L	-
Long-Term Debt Issued, Total	-	-	23Cr	17Cr	13Cr
Total Debt Issued	5Cr	10Cr	23Cr	17Cr	13Cr
Short Term Debt Repaid, Total	-6.5Cr	-2Cr	-16Cr	-	-
Long-Term Debt Repaid, Total	-	-	-	-11Cr	-18Cr
Total Debt Repaid	-6.5Cr	-2Cr	-16Cr	-11Cr	-18Cr
Issuance of Common Stock	51Cr	-	-	-	-
Repurchase of Common Stock	-	-	-	-2.1Cr	-
Common Dividends Paid	-11.54L	-5.08Cr	-32.53L	-1.71Cr	-87.89L
Common & Preferred Stock Dividends Paid	-11.54L	-5.08Cr	-32.53L	-1.71Cr	-87.89L
Other Financing Activities, Total	-4.84Cr	1.59Cr	-99.72L	2.07Cr	-8.66Cr
Cash from Financing	44Cr	4.5Cr	6.09Cr	4.06Cr	-15Cr
Foreign Exchange Rate Adjustments	-	-	-	-	-1.46T
Net Change in Cash	38Cr	-16Cr	49.1L	-22Cr	-2.48Cr
Supplemental Items
Cash Income Tax Paid (Refund)	6.71Cr	3.93Cr	3.83Cr	1.78Cr	88.23L
Levered Free Cash Flow	1.18Cr	-3.72Cr	-80.28L	-8.37Cr	4.34Cr
Unlevered Free Cash Flow	1.25Cr	-3.63Cr	-60.83L	-7.87Cr	4.34Cr
Change In Net Working Capital	3.71Cr	2.16Cr	12.19L	1.27Cr	-15Cr
Net Debt Issued / Repaid	-1.5Cr	8Cr	7.41Cr	5.8Cr	-5.62Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.38	0.13	-0.05	-4.21	-4.19
Return on Total Capital	7.19	0.14	-0.05	-4.79	-5.4
Return On Equity %	12.8	2.41	2.17	-10.8	-19.23
Return on Common Equity	13.23	2.65	2.47	-8.65	-16.33
Margin Analysis
Gross Profit Margin %	88.59	76.89	68.24	38.15	8.17
SG&A Margin	70.77	68.01	60.46	56.12	51.89
EBITDA Margin %	14.36	4.08	5.2	-25.39	-29.42
EBITA Margin %	11.86	0.58	-0.03	-36.06	-59.88
EBIT Margin %	11.78	0.45	-0.22	-36.49	-61.3
Income From Continuing Operations Margin %	12.44	4.63	5.11	-35.33	-85.88
Net Income Margin %	12.94	5.11	5.64	-26.04	-66.27
Net Avail. For Common Margin %	12.94	5.11	5.64	-26.04	-66.27
Normalized Net Income Margin	7.85	1.97	2.29	-13.41	-31.18
Levered Free Cash Flow Margin	2.22	-9.27	-2.4	-34.78	28.13
Unlevered Free Cash Flow Margin	2.36	-9.06	-1.82	-32.73	28.13
Asset Turnover
Asset Turnover	0.87	0.46	0.34	0.18	0.11
Fixed Assets Turnover	4.91	3.75	2.09	0.56	0.23
Receivables Turnover (Average Receivables)	5.17	4.16	3.75	2.48	1.57
Inventory Turnover (Average Inventory)	4.9	4.35	3.22	3.77	2.19
Short Term Liquidity
Current Ratio	11.61	4.48	5.02	1.24	0.74
Quick Ratio	11.36	4.19	4.49	1.04	0.48
Operating Cash Flow to Current Liabilities	0.77	0.01	0.1	-0.13	-0.1
Days Sales Outstanding (Average Receivables)	70.63	87.67	97.25	147.55	231.81
Days Outstanding Inventory (Average Inventory)	74.45	83.87	113.25	97.11	166.79
Average Days Payable Outstanding	291.38	55.46	66.61	96.18	137.87
Cash Conversion Cycle (Average Days)	-146.3	116.08	143.89	148.49	260.73
Long Term Solvency
Total Debt/Equity	2.6	13.44	21.92	71.47	43.36
Total Debt / Total Capital	2.53	11.85	17.98	41.68	30.24
LT Debt/Equity	-	0.12	14.41	19.21	14.79
Long-Term Debt / Total Capital	-	0.1	11.82	11.2	10.32
Total Liabilities / Total Assets	7.37	16.18	23.37	50.91	51.41
EBIT / Interest Expense	52.93	1.33	-0.24	-11.12	-
EBITDA / Interest Expense	65.48	12.87	5.77	-7.41	-
(EBITDA - Capex) / Interest Expense	60.95	-11.19	-1.84	-12.59	-
Total Debt / EBITDA	0.27	5.78	10.03	-9.2	-6.23
Net Debt / EBITDA	-7.65	-23.11	-16.86	-2.3	-3.8
Total Debt / (EBITDA - Capex)	0.29	-6.65	-31.43	-5.41	-1.86
Net Debt / (EBITDA - Capex)	-8.22	26.57	52.82	-1.35	-1.14
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.05	-24.28	-16.64	-28.02	-35.93
Gross Profit, 1 Yr. Growth %	5.28	-34.28	-26.03	-59.75	-86.27
EBITDA, 1 Yr. Growth %	-2.41	-78.48	5.65	-487.74	-25.76
EBITA, 1 Yr. Growth %	-5.16	-96.29	-103.78	4.99T	6.39
EBIT, 1 Yr. Growth %	-5.2	-97.09	-141.15	3.32T	7.63
Earnings From Cont. Operations, 1 Yr. Growth %	-26.51	-71.78	-8.03	-597.46	55.72
Net Income, 1 Yr. Growth %	-25.53	-70.07	-8.05	-432.44	63.04
Normalized Net Income, 1 Yr. Growth %	-1.17	-81.03	-2.84	-522.88	49.05
Diluted EPS Before Extra, 1 Yr. Growth %	-31.37	-75.24	-7.69	-429.17	63.29
Accounts Receivable, 1 Yr. Growth %	-4.12	-8	-7.36	26.24	-18.57
Inventory, 1 Yr. Growth %	-33.75	233.55	1.1	38.4	82.21
Net Property, Plant and Equip., 1 Yr. Growth %	-7.77	7.03	89.56	211.15	6.39
Total Assets, 1 Yr. Growth %	129.49	5.57	19.29	43.15	-16.4
Tangible Book Value, 1 Yr. Growth %	244.85	-5.9	0.53	-21.13	-17.25
Common Equity, 1 Yr. Growth %	227.16	-5.22	2.73	-12.35	-15.1
Cash From Operations, 1 Yr. Growth %	-24.34	-97.66	1T	-641.19	-31.77
Capital Expenditures, 1 Yr. Growth %	-89.48	512.19	-27.61	72.72	148.85
Levered Free Cash Flow, 1 Yr. Growth %	-127.62	-416.15	-78.41	812.78	-151.83
Unlevered Free Cash Flow, 1 Yr. Growth %	-130.22	-390.71	-83.26	990.25	-155.08
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	8.56	-9.55	-20.55	-22.54	-32.09
Gross Profit, 2 Yr. CAGR %	4.91	-16.82	-30.27	-45.44	-76.5
EBITDA, 2 Yr. CAGR %	5.55	-54.18	-52.21	92.76	69.67
EBITA, 2 Yr. CAGR %	3.3	-81.25	-96.2	500.69	635.73
EBIT, 2 Yr. CAGR %	3.26	-83.4	-89.07	596.07	506.44
Earnings From Cont. Operations, 2 Yr. CAGR %	-3.77	-54.46	-49.06	113.9	178.33
Net Income, 2 Yr. CAGR %	-2.26	-52.79	-47.54	74.83	132.81
Normalized Net Income, 2 Yr. CAGR %	7.66	-56.71	-57.07	102.25	151.06
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-58.78	-52.19	74.31	131.84
Accounts Receivable, 2 Yr. CAGR %	5.72	-6.08	-7.68	8.14	1.39
Inventory, 2 Yr. CAGR %	21.25	48.66	83.63	18.29	58.8
Net Property, Plant and Equip., 2 Yr. CAGR %	14.7	-0.64	42.44	142.86	81.94
Total Assets, 2 Yr. CAGR %	70.1	55.65	12.22	30.68	9.4
Tangible Book Value, 2 Yr. CAGR %	137.49	80.14	-2.74	-10.96	-19.21
Common Equity, 2 Yr. CAGR %	129.63	76.09	-1.32	-5.11	-13.74
Cash From Operations, 2 Yr. CAGR %	16.83	-86.69	-49.23	672.19	92.15
Capital Expenditures, 2 Yr. CAGR %	-35.07	-19.76	110.51	11.81	107.32
Levered Free Cash Flow, 2 Yr. CAGR %	-14.73	-6.56	-17.38	50.02	117.5
Unlevered Free Cash Flow, 2 Yr. CAGR %	-8.08	-6.27	-30.24	47.22	145.05
Dividend Per Share, 2 Yr. CAGR %	-	-	-55.28	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	14.93	-3.73	-11.98	-23.12	-27.29
Gross Profit, 3 Yr. CAGR %	12.47	-10.24	-20.01	-41.94	-65.56
EBITDA, 3 Yr. CAGR %	8.75	-37.88	-39.37	-7.04	40.25
EBITA, 3 Yr. CAGR %	5.53	-65.93	-88.89	11.35	237.34
EBIT, 3 Yr. CAGR %	5.54	-68.59	-77.54	12.07	273.61
Earnings From Cont. Operations, 3 Yr. CAGR %	16.05	-36.07	-42.44	8.89	92.42
Net Income, 3 Yr. CAGR %	16.5	-34.12	-41.04	-2.93	70.81
Normalized Net Income, 3 Yr. CAGR %	7.53	-39.65	-43.32	-8.12	82.68
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-46.07	-9.05	70.56
Accounts Receivable, 3 Yr. CAGR %	4.16	0.94	-6.51	2.47	-1.62
Inventory, 3 Yr. CAGR %	6.96	69.89	30.73	67.11	36.61
Net Property, Plant and Equip., 3 Yr. CAGR %	10.52	12.08	23.23	84.82	84.45
Total Assets, 3 Yr. CAGR %	53.65	45.1	42.44	21.71	12.6
Tangible Book Value, 3 Yr. CAGR %	133.35	74.43	48.31	-9.3	-13.1
Common Equity, 3 Yr. CAGR %	120.25	70.97	47.14	-5.14	-8.56
Cash From Operations, 3 Yr. CAGR %	-9.73	-68.27	-42.01	11.74	243.93
Capital Expenditures, 3 Yr. CAGR %	-29.24	37.17	-22.47	97.07	45.99
Levered Free Cash Flow, 3 Yr. CAGR %	-	31.97	-42.66	92.34	5.27
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	34.93	-47.21	84.7	6.08
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-0.85	-11.75	-20.65
Gross Profit, 5 Yr. CAGR %	-	-	-7.11	-26.44	-50.99
EBITDA, 5 Yr. CAGR %	-	-	-21.73	-2.2	-10.26
EBITA, 5 Yr. CAGR %	-	-	-72.07	8.06	6.86
EBIT, 5 Yr. CAGR %	-	-	-57.39	8.46	7.51
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-16.51	3.63	8.12
Net Income, 5 Yr. CAGR %	-	-	-15.33	-2.66	2.12
Normalized Net Income, 5 Yr. CAGR %	-	-	-25.52	-2.1	3.9
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	-3.35
Accounts Receivable, 5 Yr. CAGR %	-	-	-0.75	3.76	-3.43
Inventory, 5 Yr. CAGR %	-	-	32.78	46.98	41.31
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	22.33	52.71	44.01
Total Assets, 5 Yr. CAGR %	-	-	35.5	39.15	28.17
Tangible Book Value, 5 Yr. CAGR %	-	-	64.43	33.3	16.32
Common Equity, 5 Yr. CAGR %	-	-	59.75	35.1	18.84
Cash From Operations, 5 Yr. CAGR %	-	-	-28.29	13.75	-6.35
Capital Expenditures, 5 Yr. CAGR %	-	-	9.45	26.4	14.91
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	38.91	0.37
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	39.72	0.96